CATALYST PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Catalyst Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 25.7 %, a 40.9% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. annual Return On Equity for 2023 was 19.8 %, a 38.7% decline from 2022.
  • Catalyst Pharmaceuticals, Inc. annual Return On Equity for 2022 was 32.2 %, a 57.7% increase from 2021.
  • Catalyst Pharmaceuticals, Inc. annual Return On Equity for 2021 was 20.4 %, a 63.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 25.7 +7.47 +40.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 14.3 -21.8 -60.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 15.6 -19.2 -55.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 19.8 -12.5 -38.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 18.3 -10.3 -36% Jul 1, 2023 Sep 30, 2023
Q2 2023 36.1 +11 +43.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 34.7 +12.6 +57% Jan 1, 2023 Mar 31, 2023
Q4 2022 32.2 +11.8 +57.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 28.5 +5.91 +26.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 25.2 -17.9 -41.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 22.1 -24.8 -52.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 20.4 -35.4 -63.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 22.6 -40.2 -64% Jul 1, 2021 Sep 30, 2021
Q2 2021 43 -1.35 -3.04% Apr 1, 2021 Jun 30, 2021
Q1 2021 46.9 -5.39 -10.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 55.8 +10.3 +22.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 62.8 +47.3 +304% Jul 1, 2020 Sep 30, 2020
Q2 2020 44.4 +65.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 52.3 +101 Jan 1, 2020 Mar 31, 2020
Q4 2019 45.5 +97.4 Oct 1, 2019 Dec 31, 2019
Q3 2019 15.5 +49.6 Jul 1, 2019 Sep 30, 2019
Q2 2019 -21 +11.7 +35.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -48.8 -14.5 -42.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -51.9 -11.4 -28% Oct 1, 2018 Dec 31, 2018
Q3 2018 -34.1 +15 +30.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -32.7 +12.2 +27.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -34.4 +8.8 +20.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -40.5 -0.15 -0.37% Oct 1, 2017 Dec 31, 2017
Q3 2017 -49.1 -8.66 -21.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -44.9 -6.88 -18.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -43.2 -7.92 -22.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -40.4 -7.41 -22.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -40.4 -8.62 -27.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -38 -1.27 -3.46% Apr 1, 2016 Jun 30, 2016
Q1 2016 -35.2 +2.86 +7.51% Jan 1, 2016 Mar 31, 2016
Q4 2015 -33 +14.5 +30.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -31.8 +14 +30.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -36.7 +19.1 +34.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -38.1 +42 +52.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -47.5 +25.9 +35.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -45.8 +27.3 +37.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -55.8 +9.06 +14% Apr 1, 2014 Jun 30, 2014
Q1 2014 -80.1 -36.5 -83.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -73.4 -24.2 -49.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -73.1 +40.9 +35.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -64.9 +51.1 +44% Apr 1, 2013 Jun 30, 2013
Q1 2013 -43.7 +112 +72% Jan 1, 2013 Mar 31, 2013
Q4 2012 -49.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -114 Jul 1, 2012 Sep 30, 2012
Q2 2012 -116 Apr 1, 2012 Jun 30, 2012
Q1 2012 -156 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.